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Background: Depression is a common and disabling condition. Since 2001, Chile has had a national program for
depression in primary care and universal access to treatment for depressed people over the age of 15. There are
National Guidelines to treat depression but no training program exists. The aim of the present study protocol is to
measure the effectiveness of a comprehensive technology-assisted training and supervision program to enhance
depression management in primary care.
Methods and design: This is a two-arm, single-blind, cluster randomized controlled trial to compare the efficacy of
the program versus usual care to treat depression in primary care clinics. In total, 434 depressed persons 18 to
65 years of age, recruited from four primary care clinics located in Santiago, will participate in the study.
Discussion: In order to ensure the quality of interventions supported by the national program for depression in
Chile, it is desirable to have training programs of proven effectiveness.
Trial registration: NCT02232854, registered on 2 September 2014.
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Worldwide, depression is one of the most common and
disabling psychiatric disorders. By 2020, depression is
projected to be the second highest cause of disability in
both sexes. It is a public health problem as a result of its
high prevalence, duration, and recurrence rates [1].
In Chile, prevalence studies carried out in the general
population reported a point prevalence of 5.5 % for de-
pressive episodes, according to the ICD-10 criteria [2],
and a 6-month prevalence of 4.7 % for major depressive
disorder [3]. Studies carried out in primary care reported
prevalence rates of around 30 % [4, 5].* Correspondence: graciela.rojas.castillo@gmail.com
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creativecommons.org/publicdomain/zero/1.0/Depression can be treated effectively with low-cost anti-
depressants or psychological interventions. For people with
persistent sub-threshold depressive symptoms or mild de-
pression, low-intensity psychosocial interventions should be
used, and for moderate or severe depression, a combination
of antidepressant medication and a high-intensity psycho-
logical intervention are recommended. Stepped-care and
collaborative models provide a framework for integration of
drug and psychological treatments and help to improve
rates of adherence to treatment [6, 7].
In Chile, a randomized controlled trial to treat depression
demonstrated the effectiveness of a stepped care program
in primary care clinics. The stepped care program included
a structured psychoeducational group led by social workers
and nurses, a systematic monitoring of clinical progress,
and structured pharmacotherapy for patients with severe or
persistent depression that was executed by trained generalicle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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ference in favor of the stepped care program compared
with the usual care across all assessed outcomes, and this
difference remained stable over a period of 6 months. This
program was more effective and only marginally more ex-
pensive than usual care for the treatment of depressed
women in primary care. Women receiving the stepped-care
program had an average of 50 additional depression-free
days over 6 months relative to patients who received usual
care [8, 9].
Since 2001, Chile has had a program for the detection,
diagnosis, and treatment of depression in primary care
clinics. It recommends algorithms for diagnostic evalu-
ation, delivery of psychosocial interventions and medica-
tions, consultations with specialists, follow-up visits, and
criteria for referral to secondary care. All persons with de-
pression have to be treated in primary care unless they
have psychosis, bipolar disorder, high suicidal risk, or a
lack of response to two courses of treatment with two dif-
ferent antidepressants at therapeutic doses, plus psycho-
social intervention [10].
In 2006, depression was incorporated into the national
health reform, thus ensuring universal access to treatment
for depressed individuals 15 and older [11], the majority
of whom are treated by primary care teams [12]. Since
2009, the Ministry of Health has published two Clinical
Guidelines for depression treatment, but no training pro-
gram has yet been recommended [10, 13].
An evaluation of the depression program carried out
at seven primary care clinics in two regions of Chile
demonstrated that diagnoses of the severity of illnesses
were inaccurate, that severity of depressive episodes was
underestimated, that treatments were not indicated
according to the severity of the illness or according
to guidelines, that adherence to treatment was insuf-
ficient − higher for pharmacological treatment and
lower for individual psychotherapy and group psy-
choeducation − and that patient dropout from the pro-
gram was around 60 % [14, 15].
International evidence indicates that, despite the high
prevalence of depression and availability of effective treat-
ments, the diagnosis and treatment of depression by gen-
eral practitioners do not follow clinical guidelines and that
these guidelines do not always include training [16, 17].
Training can improve the detection, diagnosis, and
treatment and could lead to better patient outcomes, al-
though studies have shown that training alone does not
result in improved outcomes [18, 19].
There is abundant literature on the effectiveness of
collaborative care on depression [20]. Systematic litera-
ture reviews of strategies employed to improve mental
health patient outcomes reported that the most effective
interventions incorporate clinician education, nurse case
management, a greater integration between primary andsecondary care [21], and quality measures to improve re-
sults [22].
For these reasons, we believe that a comprehensive
technology-assisted training and supervision program
can improve depression management in primary care
clinics in Santiago, Chile.
Methods and design
This is a two-arm, single-blind (blinded only to outcome
evaluator), cluster randomized controlled trial, which will
compare the effectiveness of a comprehensive technology-
assisted training and supervision program for depression
management versus usual depression care in primary care
clinics in Santiago, Chile.
Aims and hypotheses
General aim
To carry out a cluster randomized controlled trial to com-
pare the efficacy of a comprehensive technology-assisted
training and supervision program versus usual care to treat
depression in primary care clinics in Santiago, Chile.
Specific aims
1. To compare the level of depressive symptoms of
adults treated for depression through a
comprehensive technology-assisted training and
supervision program versus usual care in primary
care clinics.
2. To compare patients’ adherence to a comprehensive
technology-assisted training and supervision
program versus usual care in primary care clinics.
3. To compare health-related quality of life of adults
suffering depression treated in a comprehensive
technology-assisted training and supervision
program versus usual care in primary care clinics.
4. To compare clinical outcomes of patients treated in
a comprehensive technology-assisted training and
supervision program versus usual care in primary
care clinics.
5. To compare use of health care services by patients
treated in a comprehensive technology-assisted
training and supervision program versus usual care
in primary care clinics.
6. To compare the rate of treated depressed cases
by teams participating in a comprehensive
technology-assisted training and supervision
program versus those following only the usual
care approach in primary care clinics.
Hypotheses
1. Adults receiving the intervention will reach clinical
remission, given by a score of 10 or less in the PHQ-9,
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group receiving the usual care, 3 and 6 months after
randomization.
2. Adults participating in the intervention program will
have (significantly) better adherence to treatment
than those receiving usual care, 3 and 6 months
after randomization.
3. Adults participating in the intervention program will
have significantly better quality of life than those
receiving usual care, 3 and 6 months after
randomization.
4. Adults participating in the intervention program will
have significantly better clinical outcomes than those
receiving usual care, 3 and 6 months after
randomization.
5. Adults participating in the intervention program will
have significantly greater service use than those
receiving usual care, 3 and 6 months after
randomization.
6. Primary care teams participating in the intervention
program will treat more depressed cases than those
that are only in the usual care program, during a 1-year
timeframe.
Setting and population
Adults between 18 and 65 years of age attending four pri-
mary care clinics located in two low-income municipalities
of Santiago, Chile.
Inclusion and exclusion criteria
Depressed adults aged between 18 and 65 years of age at-
tending primary care clinics will be invited to participate.
Informed consent will be obtained from each participant.
Depression will be assessed with the Patient Health
Questionnaire-Nine items (PHQ-9) and the Mini-Inter-
national Neuropsychiatric Interview (MINI). Individuals
currently receiving treatment for depression and/or
those without access to a telephone will be excluded.
Intervention arm
The intervention arm includes a 16-h training program for
primary care teams (physicians, psychologists, social
workers, nurses, midwives, and occupational therapists) to
ensure compliance with the Clinical Guidelines for the
Treatment of Depression, issued by the Chilean Ministry of
Health [10]. The workshop will include a seminar on the
detection, diagnosis, and treatment of depression; discus-
sion of clinical cases; and role-playing to enhance clinical
skills and to apply problem-solving techniques. Finally,
trained primary care teams will undergo an Objective
Structured Clinical Examination (OSCE) for evaluation.
After the training, a focus group between primary
health care teams and study researchers will be held
in order to address barriers to the implementation ofclinical guidelines. In order to develop a comprehensive
supervision program, trained administrative staff will con-
tact patients from a call center to support treatment ad-
herence, and a psychiatrists will supervise the primary
care team, using a web-based platform.
Control arm
The control arm will receive treatment as usual − all the
interventions that are guaranteed for persons with de-
pression from the primary care clinics and if needed re-
ferral to the specialized psychiatric service, as indicated
by the national depression program. Professionals will be




Depressive symptoms will be assessed as the primary out-
come, using the Patient Health Questionnaire-9 item
(PHQ-9) [23]. The PHQ-9 is a nine-item self-administered
measure of depression, with documented reliability and
validity in the sample population [24]. It is a dual-purpose
instrument that, with the same nine items, can establish
provisional depressive disorder diagnoses, as well as deter-
mine depressive symptom severity. Major depression is di-
agnosed if five or more of the nine depressive symptom
criteria have been present at least “more than half the days”
in the past 2 weeks, and one of the symptoms is depressed
mood or anhedonia. As a severity measure, the PHQ-9
score ranges from 0 to 27 [23]. A score equal to 10 points
or higher is indicative of major depressive syndrome. Sever-
ity can be categorized as follows: healthy (1–5), subclinical
depressive symptoms (6–10), mild depression (11–15),
moderate depression (16–20), and severe depression
(21–27) [22]. In primary care studies, the questionnaire
has a sensitivity for major depression of 88 %, specifi-
city of 88 %, and positive likelihood ratio of 7.1 [23]. It
was validated in a Chilean population [25].
Secondary outcome measures
1) Health-related quality of life will be measured as a
secondary outcome, using the Short Form-36 Health
Survey (SF-36). It is a patient-reported and subjective
measure of generic health-related quality of life
[26, 27]. The SF-36 has eight subscales and two
summary measures (physical and mental
components), and each scale is transformed to a
score from 0 (worse health status) to 100 (best
health status). It has been validated [28] in Chile
and has been widely used [29, 30].
2) Clinical outcomes will be measured using the Outcome
Questionnaire (OQ 45.2). It is a self-administered,
45-item instrument that measures psychotherapy
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and also widely used [33–35]. It considers three
domains: symptoms and distress, interpersonal
relationships, and social role.
Other outcomes
Patients' adherence to treatment and use of health care
services will be measured at 3 and 6 months after the
baseline assessment. At the primary care team level, the
rate of treated depressed cases will be measured 12 months
before and after randomization.
Sample size
Sample size calculation was done based on two studies pre-
viously carried out in Chile [36, 15]. A randomized clinical
trial that compared pharmacotherapy monitored by tele-
phone with usual care in primary care clinics in Chile found
a recovery rate for depressive disorders of 62 % in the inter-
vention group versus 38 % in the control group [36], having
an effect size of 20 %. Since the current study protocol aims
to test whether the intervention is better than usual care, a
one-sided test is appropriate to detect an effect. Moreover,
it is expected that the intervention will have a favorable ef-
fect ruling out the possibility of a statistically significant
negative effect. To detect a difference of 20 %, in a one-
sided model, with an alpha of 5 % and power of 80 %, 152
depressed persons, 76 in each group (intervention and con-
trol), will be required for the study. Using a database from
another study comprising 201 persons treated for depres-
sion in seven primary care clinics [15], an intraclass correl-
ation coefficient (ICC) of 0.03839 was estimated. Therefore,
a design effect of 2.42 was determined, based on the previ-
ously calculated ICC and the use of four clusters (primary
care clinics). After applying the design effect, the sample
needed increased to 368 depressed persons. Considering a
retention rate of approximately 85 %, 434 depressed cases
will be required for the study, hence 109 cases in each of
the four primary health care clinics.
Finally, a group of four primary health care clinics was
chosen for two reasons: the usual flow of patients with de-
pression presenting at each of the participating primary
care clinics, which allows for a high number of potential
participants per clinic, and financial constraints restricted
the number of clusters, since having more primary care
clinics would put in jeopardy the feasibility of the study.
Recruitment
After being informed of the study by primary health care
professionals, interested potential participants with possible
cases of depression identified in routine clinical practice will
be invited for an on-site or telephone evaluation by a study
psychologist, who will obtain participants' informed con-
sent, carry out a baseline evaluation and determine whether
or not a potential participants fit study criteria.Group assignment
Clustered treatment assignment will be performed. First,
two urban municipalities of the Metropolitan Region of
Santiago, Chile, which collaborate with the Faculty of
Medicine of Universidad de Chile and have at least two
primary health care clinics, will be randomly selected
through simple random sampling. Municipalities with a
high Human Development Index, a high percentage of
immigrants and older population, and psychiatry resi-
dents working in primary health care clinics will be ex-
cluded. In each selected municipality, the two primary
health care clinics with the highest registered number of
patients will be randomly assigned to the active or the
control arm, through simple random sampling, thus
selecting a total of four primary health care centers,
one from the intervention arm and one from the con-
trol arm, in each selected municipality. This matching
was done in order to ensure similarity between the pa-
tients’ socioeconomic levels and the administration and
organization of the primary care centers, since all cen-
ters within a municipality are overseen by the same
administration.
Data collection
All participants will be assessed at baseline and at 3 and
6 months after recruitment. Independent interviewers
blind to treatment assignment evaluated participants at 3
and 6 months after baseline assessment. The interviewers
received an 8-h training to ensure standardization of data
collection, which will be performed using digital PDF
forms. Interviewers and patients will use computer tablets
for data entry.
Data management
Data collection is expected to be completed in late 2015.
After each evaluation is complete, encrypted data entry
forms will be sent by the interviewers via secure password-
protected e-mail to the data management center. No copy
of the data will remain on the computer tablets. Informa-
tion will be compiled and exported to the CSV format for
analysis in the SPSS software [37]. Only the principal inves-
tigator and co-investigator in charge of data management
and analysis will have access to these data. Data will be
encrypted and stored in a local hard drive. Subjects' identi-
fying information will be eliminated from the database and
preserved in a secure location. Data will only be identified
by a unique ID code to ensure participants' anonymity.
Data analysis
Data analysis will be performed using SPSS software [37],
with which scores of the used scales will be calculated. Data
and presentation of the results will be in accordance with
CONSORT guideline for randomized clinical trials [38] as
well as its extensions to cluster and non-pharmacological
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conducted on an intention-to-treat basis. Initially, we will
conduct descriptive analysis to assess the balance between
the two groups. The primary analysis will employ multivari-
able linear regression to investigate differences in mean
symptom scores (the primary outcome measure) between
groups at 3 and 6 months after randomization, adjusting
for baseline outcome variables if imbalances are identified.
Sensitivity analysis based on different assumptions will be
conducted to investigate the potential effects of missing
data. Similar analysis will be carried out for secondary out-
come measures.
Monitoring
The primary care center staff will be told to report any type
of adverse event (for example, hospitalization, pregnancy,
suicide attempt) affecting the participants to the principal
investigator, who will then take appropriate measures to en-
sure the safety and wellbeing of the participants.
Research governance and ethics
Trial management
The study will comply with local research governance
requirements.
Ethics
Full ethical approval was obtained from the local Ethics
Committee (Faculty of Medicine, Universidad de Chile,
project no. 103–2012). Informed and written consent
will be obtained from the participants.
Discussion
To date, only a single study in Latin America has evaluated
changes in the knowledge, attitudes, and practice among
primary care physicians who participated in a depression
training program, finding limited impact on daily practice a
month after the training program, measured through
rates of diagnosis, referrals, antidepressant prescription,
and provision of supportive therapy [39].
In contrast to the study mentioned above, our research
protocol aims to evaluate the effectiveness of a training pro-
gram in improving patients' outcomes and focuses not only
on training primary care physicians in managing depres-
sion, but also the primary health care team as a whole in
order to develop a comprehensive approach to depression
management, which is further reinforced by a technology-
assisted supervision program.
The aforementioned makes our study the first of its kind
in a Latin American country. We believe that the training
and supervision program can contribute to the Chilean na-
tional depression program, which is implemented in all the
primary care clinics of the country despite primary care
teams not currently being trained to follow the Ministry ofHealth recommendations for the correct detection, diagno-
sis, and treatment of depression [10].
Trial status
The study started recruiting patients in June 2014.
Recruitment will end by July 2015.
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